Disclosed are 2 3 dihydroimidazo[1 2 c]pyrimidin 5(1H) one compounds that inhibit Lp PLA processes for their preparation compositions containing them and their use in the treatment of diseases associated with the activity of Lp PLA for example atherosclerosis Alzheimer s disease.